We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Genomic characterization of Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae (KPC-Kp) strains circulating in three university hospitals in Northern Italy over three years

    Objectives

    Genomic surveillance of Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae (KPC-Kp) is crucial for virulence,...

    Valeria Fox, Davide Mangioni, ... Claudia Alteri in Antimicrobial Resistance & Infection Control
    Article Open access 03 July 2024
  2. Sex-dependent APOE4 neutrophil–microglia interactions drive cognitive impairment in Alzheimer’s disease

    APOE4 is the strongest genetic risk factor for Alzheimer’s disease (AD), with increased odds ratios in female carriers. Targeting amyloid plaques...

    Neta Rosenzweig, Kilian L. Kleemann, ... Oleg Butovsky in Nature Medicine
    Article 03 July 2024
  3. Building genomic capacity for precision health in Africa

    The African continent is poised to have a pivotal role in the global population landscape, with the United Nations projecting a population of 2.5...

    Alhaji Olono, Vera Mitesser, ... Christian Happi in Nature Medicine
    Article 03 July 2024
  4. PI3Kγ in B cells promotes antibody responses and generation of antibody-secreting cells

    The differentiation of naive and memory B cells into antibody-secreting cells (ASCs) is a key feature of adaptive immunity. The requirement for...

    Stephen M. Lanahan, Lucas Yang, ... Carrie L. Lucas in Nature Immunology
    Article 03 July 2024
  5. A unified metric of human immune health

    Immunological health has been challenging to characterize but could be defined as the absence of immune pathology. While shared features of some...

    Rachel Sparks, Nicholas Rachmaninoff, ... John S. Tsang in Nature Medicine
    Article 03 July 2024
  6. Slow recovery rates and spatial aggregation of Triatoma infestans populations in an area with high pyrethroid resistance in the Argentine Chaco

    Background

    The emergence of pyrethroid resistance has threatened the elimination of Triatoma infestans from the Gran Chaco ecoregion. We investigated...

    María Carla Cecere, María Sol Gaspe, ... Ricardo Esteban Gürtler in Parasites & Vectors
    Article Open access 02 July 2024
  7. Intestinal microbiota imbalance resulted by anti-Toxoplasma gondii immune responses aggravate gut and brain injury

    Background

    Toxoplasma gondii infection affects a significant portion of the global population, leading to severe toxoplasmosis and, in...

    Jiating Chen, Chi Zhang, ... Hongjuan Peng in Parasites & Vectors
    Article Open access 02 July 2024
  8. Pan-cancer profiling of tumor-infiltrating natural killer cells through transcriptional reference map**

    The functional diversity of natural killer (NK) cell repertoires stems from differentiation, homeostatic, receptor–ligand interactions and...

    Herman Netskar, Aline Pfefferle, ... Karl-Johan Malmberg in Nature Immunology
    Article Open access 02 July 2024
  9. High-dimensional single-cell analysis of human natural killer cell heterogeneity

    Natural killer (NK) cells are innate lymphoid cells (ILCs) contributing to immune responses to microbes and tumors. Historically, their...

    Lucas Rebuffet, Janine E. Melsen, ... Eric Vivier in Nature Immunology
    Article Open access 02 July 2024
  10. Overwintering West Nile virus in active Culex pipiens mosquito populations in Greece

    The flavivirus West Nile Virus (WNV), which is transmitted by mosquitoes, poses a significant threat to both humans and animals, and its outbreaks...

    Georgios Balatsos, Stavroula Beleri, ... Eleni Patsoula in Parasites & Vectors
    Article Open access 02 July 2024
  11. Is Culex modestus a New Usutu virus vector?

    Usutu virus is an emerging pathogen transmitted by mosquitoes. Culex modestus mosquitoes are widespread in Europe, but their role in disease...

    Alina Soto, Lotte Wauters, Leen Delang in Parasites & Vectors
    Article Open access 02 July 2024
  12. Benefits for children with suspected cancer from routine whole-genome sequencing

    Clinical whole-genome sequencing (WGS) has been shown to deliver potential benefits to children with cancer and to alter treatment in high-risk...

    Angus Hodder, Sarah M. Leiter, ... Sam Behjati in Nature Medicine
    Article Open access 02 July 2024
  13. A modified mycobacterial growth inhibition assay for the functional assessment of vaccine-mediated immunity

    The Mycobacterial growth inhibition assay (MGIA) is an ex-vivo assay used to measure the overall functional immune response elicited by infection or...

    Emil Joseph Vergara, Andy Cano Tran, ... Rajko Reljic in npj Vaccines
    Article Open access 02 July 2024
  14. Genetic Evaluation of the Patients with Clinically Diagnosed Inborn Errors of Immunity by Whole Exome Sequencing: Results from a Specialized Research Center for Immunodeficiency in Türkiye

    Molecular diagnosis of inborn errors of immunity (IEI) plays a critical role in determining patients’ long-term prognosis, treatment options, and...

    Baran Erman, Umran Aba, ... Ilhan Tezcan in Journal of Clinical Immunology
    Article Open access 02 July 2024
  15. Effects of intermittent senolytic therapy on bone metabolism in postmenopausal women: a phase 2 randomized controlled trial

    Preclinical evidence demonstrates that senescent cells accumulate with aging and that senolytics delay multiple age-related morbidities, including...

    Joshua N. Farr, Elizabeth J. Atkinson, ... Sundeep Khosla in Nature Medicine
    Article 02 July 2024
  16. Diversity of group 1 innate lymphoid cells in human tissues

    Group 1 innate lymphoid cells (ILC1s) are cytotoxic and interferon gamma-producing lymphocytes lacking antigen-specific receptors, which include...

    Natalia Jaeger, Alina Ulezko Antonova, ... Marco Colonna in Nature Immunology
    Article 02 July 2024
  17. Neoadjuvant chemotherapy with or without camrelizumab in resectable esophageal squamous cell carcinoma: the randomized phase 3 ESCORT-NEO/NCCES01 trial

    Recent single-arm studies involving neoadjuvant camrelizumab, a PD-1 inhibitor, plus chemotherapy for resectable locally advanced esophageal squamous...

    Jianjun Qin, Liyan Xue, ... Yin Li in Nature Medicine
    Article Open access 02 July 2024
Did you find what you were looking for? Share feedback.